SG11201507450TA - Antiemetic extended release solid dosage forms - Google Patents
Antiemetic extended release solid dosage formsInfo
- Publication number
- SG11201507450TA SG11201507450TA SG11201507450TA SG11201507450TA SG11201507450TA SG 11201507450T A SG11201507450T A SG 11201507450TA SG 11201507450T A SG11201507450T A SG 11201507450TA SG 11201507450T A SG11201507450T A SG 11201507450TA SG 11201507450T A SG11201507450T A SG 11201507450TA
- Authority
- SG
- Singapore
- Prior art keywords
- dosage forms
- solid dosage
- extended release
- release solid
- antiemetic
- Prior art date
Links
- 230000003474 anti-emetic effect Effects 0.000 title 1
- 239000002111 antiemetic agent Substances 0.000 title 1
- 238000013265 extended release Methods 0.000 title 1
- 239000007909 solid dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361782395P | 2013-03-14 | 2013-03-14 | |
| PCT/IB2014/001633 WO2014181195A2 (en) | 2013-03-14 | 2014-03-14 | Antiemetic extended release solid dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507450TA true SG11201507450TA (en) | 2015-10-29 |
Family
ID=51528070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507450TA SG11201507450TA (en) | 2013-03-14 | 2014-03-14 | Antiemetic extended release solid dosage forms |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US20140271851A1 (de) |
| EP (1) | EP2983664B1 (de) |
| JP (1) | JP6282676B2 (de) |
| KR (1) | KR102270521B1 (de) |
| CN (2) | CN112274489A (de) |
| AU (1) | AU2014264342B2 (de) |
| BR (1) | BR112015022398B1 (de) |
| CA (1) | CA2905553C (de) |
| CL (1) | CL2015002666A1 (de) |
| ES (1) | ES2946985T3 (de) |
| HK (1) | HK1223012A1 (de) |
| IL (1) | IL241580B (de) |
| MX (1) | MX2015012970A (de) |
| NZ (1) | NZ712159A (de) |
| PH (1) | PH12015502093B1 (de) |
| RU (1) | RU2679448C2 (de) |
| SG (1) | SG11201507450TA (de) |
| WO (2) | WO2014181195A2 (de) |
| ZA (1) | ZA201506961B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014181195A2 (en) | 2013-03-14 | 2014-11-13 | Redhill Biopharma Ltd. | Antiemetic extended release solid dosage forms |
| KR20160132057A (ko) | 2014-03-11 | 2016-11-16 | 레드힐 바이오파마 엘티디 | 구역, 구토 또는 설사 증상 치료용 온단세트론 연장 방출형 고체 제형 |
| CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
| KR102300335B1 (ko) * | 2018-10-19 | 2021-09-10 | 주식회사 삼양홀딩스 | 아프레피탄트의 경구용 조성물 |
| WO2024096892A1 (en) * | 2022-11-03 | 2024-05-10 | Lumos Pharma, Inc. | Compactable oral formulations of ibutamoren |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4720353A (en) * | 1987-04-14 | 1988-01-19 | Richardson-Vicks Inc. | Stable pharmaceutical w/o emulsion composition |
| US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
| US6733789B1 (en) * | 1999-01-21 | 2004-05-11 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
| EP1239840B1 (de) * | 1999-12-09 | 2005-04-06 | Alza Corporation | Antivirale arznei |
| US6936275B2 (en) | 1999-12-20 | 2005-08-30 | Scolr, Inc. | Amino acid modulated extended release dosage form |
| WO2003024427A1 (en) | 1999-12-20 | 2003-03-27 | Temple University Of The Commonwealth System Of Higher Education | Tableted oral extended release dosage form |
| US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
| US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| US20020172712A1 (en) | 2001-03-19 | 2002-11-21 | Alan Drizen | Antiemetic, anti-motion sustained release drug delivery system |
| GB0119012D0 (en) * | 2001-08-03 | 2001-09-26 | Strakan Group Plc | Transdermal delivery of drugs |
| GB0129489D0 (en) * | 2001-12-10 | 2002-01-30 | Quadrant Healthcare Uk Ltd | Sustained-release compositions |
| US20050131045A1 (en) | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| US7704527B2 (en) | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
| AU2004204827B2 (en) | 2003-01-13 | 2006-06-29 | Dynogen Pharmaceuticals, Inc. | Method of treating nausea, vomiting, retching or any combination thereof |
| PL1683526T3 (pl) | 2003-11-14 | 2012-09-28 | Senju Pharma Co | Preparat wodnego roztworu zawierający antybiotyk aminoglikozydowy i bromfenak |
| CA2579767A1 (en) * | 2004-04-30 | 2005-11-10 | Astellas Pharma Inc. | Oral pharmaceutical composition in timed-release particle form and fast-disintegrating tablets containing this composition |
| KR20070087678A (ko) * | 2004-12-20 | 2007-08-28 | 컬리지움 파마슈티칼, 인코포레이티드 | 수면 장애용 약제 조성물 |
| WO2007073702A2 (es) * | 2005-12-29 | 2007-07-05 | Osmotica Corp. | Comprimido multicapa con combinación de triple liberación |
| US20070190141A1 (en) | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
| US20080004260A1 (en) | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
| SI2051704T1 (sl) | 2006-08-18 | 2012-08-31 | Evonik Roehm Gmbh | Farmacevtski sestavek s kontroliranim sproščanjem aktivne učinkovine za aktivne učinkovine z dobro topnostjo v vodi |
| CN100584319C (zh) | 2006-10-16 | 2010-01-27 | 北京科信必成医药科技发展有限公司 | 群孔释放渗透泵控释片及其制备方法 |
| US20080113021A1 (en) | 2006-10-25 | 2008-05-15 | Robert Shen | Ibuprofen composition |
| GB0624087D0 (en) | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| WO2008079805A1 (en) | 2006-12-22 | 2008-07-03 | 3M Innovative Properties Company | Controlled release composition and process |
| WO2009118763A1 (en) | 2008-03-28 | 2009-10-01 | Panacea Biotec Limited | Multilayered pharmaceutical compositions and processes thereof |
| US20100196291A1 (en) | 2009-01-30 | 2010-08-05 | Laurence Halimi | Personal care sunscreen compositions having reduced eye irritation |
| EP2403487A2 (de) | 2009-03-04 | 2012-01-11 | Fdc Limited | Orale darreichungsformen mit verzögerter freisetzung für wasserlösliche arzneimittel |
| US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| RU2427389C2 (ru) * | 2009-10-09 | 2011-08-27 | Александр Владимирович Диковский | Фармацевтическая композиция для профилактики и лечения инфекционных и неинфекционных диарей |
| CA2782163A1 (en) * | 2009-11-30 | 2011-06-03 | Aptalis Pharmatech, Inc. | Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting |
| BR112012015282A2 (pt) * | 2009-12-22 | 2016-03-15 | Abbott Healthcare Private Ltd | composição farmacêutica de liberação controlada |
| AU2010343147A1 (en) | 2009-12-28 | 2012-07-19 | Monosol Rx, Llc | Orally administrable film dosage forms containing ondansetron |
| US8916194B2 (en) | 2010-08-30 | 2014-12-23 | Lupin Limited | Controlled release pharmaceutical compositions of milnacipran |
| US20120128730A1 (en) * | 2010-11-23 | 2012-05-24 | Nipun Davar | Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron |
| WO2014181195A2 (en) | 2013-03-14 | 2014-11-13 | Redhill Biopharma Ltd. | Antiemetic extended release solid dosage forms |
-
2014
- 2014-03-14 WO PCT/IB2014/001633 patent/WO2014181195A2/en active Application Filing
- 2014-03-14 EP EP14795266.7A patent/EP2983664B1/de active Active
- 2014-03-14 AU AU2014264342A patent/AU2014264342B2/en active Active
- 2014-03-14 US US14/212,954 patent/US20140271851A1/en not_active Abandoned
- 2014-03-14 NZ NZ712159A patent/NZ712159A/en not_active IP Right Cessation
- 2014-03-14 RU RU2015143993A patent/RU2679448C2/ru active
- 2014-03-14 MX MX2015012970A patent/MX2015012970A/es unknown
- 2014-03-14 CA CA2905553A patent/CA2905553C/en active Active
- 2014-03-14 US US14/212,694 patent/US9636305B2/en active Active
- 2014-03-14 SG SG11201507450TA patent/SG11201507450TA/en unknown
- 2014-03-14 KR KR1020157028825A patent/KR102270521B1/ko active IP Right Grant
- 2014-03-14 CN CN202011222247.XA patent/CN112274489A/zh active Pending
- 2014-03-14 ES ES14795266T patent/ES2946985T3/es active Active
- 2014-03-14 JP JP2015562425A patent/JP6282676B2/ja active Active
- 2014-03-14 CN CN201480024401.9A patent/CN105530935A/zh active Pending
- 2014-03-14 WO PCT/IB2014/001589 patent/WO2014184662A2/en active Application Filing
- 2014-03-14 BR BR112015022398-2A patent/BR112015022398B1/pt active IP Right Grant
-
2015
- 2015-09-10 IL IL241580A patent/IL241580B/en active IP Right Grant
- 2015-09-14 PH PH12015502093A patent/PH12015502093B1/en unknown
- 2015-09-14 CL CL2015002666A patent/CL2015002666A1/es unknown
- 2015-09-18 ZA ZA2015/06961A patent/ZA201506961B/en unknown
-
2016
- 2016-09-20 HK HK16111017.8A patent/HK1223012A1/zh unknown
-
2017
- 2017-03-22 US US15/466,214 patent/US20170189340A1/en not_active Abandoned
- 2017-08-16 US US15/678,386 patent/US20180028452A1/en not_active Abandoned
-
2020
- 2020-07-01 US US16/918,538 patent/US20200330392A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223856A1 (zh) | 立即釋放型濫用制止粒狀劑型 | |
| HK1222846A1 (zh) | 取代的苄基吡唑 | |
| HK1221717A1 (zh) | 取代的苄基吡唑 | |
| EP3065716C0 (de) | Formulierungen | |
| HRP20171890T1 (hr) | Supstituirani imidazopiridazini | |
| GB201319792D0 (en) | Formulations | |
| HK1223362A1 (zh) | 取代的吡唑並吡啶胺 | |
| HK1220972A1 (zh) | 取代的噻唑並嘧啶 | |
| PL3021658T3 (pl) | Prasa do belowania | |
| HK1214951A1 (zh) | 眼用製劑 | |
| IL245125B (en) | Immediate-release granulated dosage forms prevent abuse | |
| PL3021659T3 (pl) | Prasa do formowania bel | |
| IL246271A0 (en) | Converted piperidinyl-tetrahydroquinolines | |
| HK1223012A1 (zh) | 抗嘔吐緩釋固體劑型 | |
| GB201315356D0 (en) | Compactor | |
| GB201306627D0 (en) | Marker | |
| EP2948129A4 (de) | Therapeutische verbindungen | |
| GB201413253D0 (en) | Solid dosage form | |
| GB201302219D0 (en) | Contraceptive compounds | |
| GB201308346D0 (en) | Double ended match | |
| GB201316662D0 (en) | Pharmaceutical Combination | |
| GB201310280D0 (en) | Odontalgic preparation | |
| GB201311169D0 (en) | Therapeutic compounds | |
| GB201306576D0 (en) | Breesy Pedal |